IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,607,216 | +97.1% | 200,401 | +264.3% | 0.00% | +200.0% |
Q1 2024 | $815,248 | +1636.5% | 55,010 | +433.1% | 0.00% | – |
Q3 2023 | $46,947 | -94.8% | 10,318 | -92.0% | 0.00% | -100.0% |
Q2 2023 | $908,843 | +51.7% | 129,097 | +31.7% | 0.00% | 0.0% |
Q1 2023 | $598,969 | -49.6% | 98,031 | -47.3% | 0.00% | -50.0% |
Q4 2022 | $1,188,252 | +353.5% | 185,955 | +3190.1% | 0.01% | +50.0% |
Q4 2020 | $262,000 | -31.2% | 5,652 | -51.2% | 0.00% | -20.0% |
Q3 2020 | $381,000 | -76.6% | 11,586 | -80.5% | 0.01% | -79.2% |
Q2 2020 | $1,629,000 | +45.2% | 59,339 | +46.4% | 0.02% | -31.4% |
Q4 2019 | $1,122,000 | – | 40,522 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
CM Management, LLC | 200,000 | $910,000 | 0.97% |
Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |